Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Populations news

Show

From To
Liver fibrosis speeds up around the menopause in women with HIV and HCV co-infection

Menopause is associated with accelerated liver fibrosis in women with HIV and hepatitis C virus (HCV) co-infection, investigators from the United States report in the online edition of

Published
10 hours ago
By
Michael Carter
PrEPster joins call for PrEP for women

PrEPster today joined with other leading PrEP advocate organisations in calling for PrEP for women in the UK.

Published
21 August 2017
From
Prepster
How PrEP changed Matt's life

The arrival of HIV/Aids in the 1980s had a devastating effect on gay communities around the world. Sexual intercourse was linked to the risk of contracting a deadly disease. We explore how pre-exposure prophylaxis (PrEP) has changed Matt's attitudes to sex.

Published
21 August 2017
From
BBC (video)
Men on PrEP & HIV-positive men are getting hepatitis C during sex—here’s why

Hepatitis C is best known as an infection transmitted by blood, with most new cases of hepatitis C caused by sharing injection drug use equipment. But this dangerous infection, which … Read More →

Published
18 August 2017
From
BETA blog
Scotland May Now Have Highest Rate of Drug-Related Deaths in the EU

Data published on August 15 by the National Records of Scotland suggest that Scotland now has the highest rate of drug-related deaths of any country in the European Union. Across Scotland, the report says, there were 160 drug-related deaths per one million people in 2016. This compares with an estimated 65.8 per million in England and Wales, and a European average of 20.3 per million.

Published
16 August 2017
From
Talking Drugs
PrEP use in US exceeds 100,000 in Gilead pharmacy survey

An estimated 120,000 people in the US have started Truvada for pre-exposure prophylaxis (PrEP) since 2012, according to the latest findings from a survey of

Published
14 August 2017
By
Liz Highleyman
No change in CDC's HIV screening recommendation for MSM

The CDC said it would not change its long-standing recommendation on how frequently to test men who have sex with men for HIV. The agency has recommended since 2006 that U.S. providers offer HIV screening to all sexually active MSM “at least annually".

Published
14 August 2017
From
Healio
Incidence of anal cancer has already peaked among HIV-positive gay men; reductions can be achieved with expanded ART coverage and screening

The incidence of anal cancer among HIV-positive gay men peaked in 2009 and will decline substantially by 2030, even with current levels of antiretroviral therapy

Published
11 August 2017
By
Michael Carter
Can new 'Smart PrEP Pills' increase adherence for HIV-prevention medication among young people?

Researchers at Cook County Health and Hospitals System are currently recruiting participants in a study to see if, as expected, the smart PrEP pill makes it easier for young people to keep track of their PrEP dosage each day and in the process, significantly reduce their chances of getting HIV/AIDS.

Published
08 August 2017
From
Chicago Daily Herald
Indonesia cracks down on gays ... and fuels its HIV epidemic

Amid an explosion of infections, a hardline stance on homosexuality is making treatment a risky business.

Published
07 August 2017
From
South China Morning Post
← First12345...336Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.